PWMG
CVS icon

Prestige Wealth Management Group’s CVS Health CVS Stock Holding History

Prestige Wealth Management Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Sell
3,341
-1,965
-37% -$175K 0.06% 130
2026
Q1 		$381K Sell
5,306
-5
-0.1% -$385 0.07% 121
2025
Q4 		$421K Buy
5,311
+3,651
+220% +$288K 0.08% 113
2025
Q3 		$125K Hold
1,660
– – 0.02% 202
2025
Q2 		$115K Buy
1,660
+42
+3% +$2.75K 0.02% 201
2025
Q1 		$110K Sell
1,618
-23
-1% -$1.38K 0.02% 193
2024
Q4 		$73.7K Sell
1,641
-36
-2% -$2.02K 0.02% 223
2024
Q3 		$105K Sell
1,677
-4
-0.2% -$233 0.02% 191
2024
Q2 		$99.3K Sell
1,681
-11
-0.7% -$688 0.02% 177
2024
Q1 		$135K Hold
1,692
– – 0.03% 180
2023
Q4 		$134K Sell
1,692
-98
-5% -$6.97K 0.03% 166
2023
Q3 		$125K Buy
1,790
+11
+0.6% +$779 0.03% 170
2023
Q2 		$123K Sell
1,779
-3,706
-68% -$264K 0.03% 187
2023
Q1 		$408K Buy
5,485
+2,061
+60% +$173K 0.1% 93
2022
Q4 		$319K Sell
3,424
-3,193
-48% -$308K 0.08% 107
2022
Q3 		$631K Buy
6,617
+473
+8% +$46.8K 0.18% 57
2022
Q2 		$570K Buy
6,144
+22
+0.4% +$2.15K 0.15% 63
2022
Q1 		$620K Buy
6,122
+4,380
+251% +$460K 0.15% 70
2021
Q4 		$180K Hold
1,742
– – 0.04% 148
2021
Q3 		$148K Hold
1,742
– – 0.04% 157
2021
Q2 		$145K Hold
1,742
– – 0.04% 158
2021
Q1 		$131K Hold
1,742
– – 0.04% 158
2020
Q4 		$119K Sell
1,742
-313
-15% -$20.4K 0.03% 158
2020
Q3 		$120K Sell
2,055
-66
-3% -$4.11K 0.04% 150
2020
Q2 		$138K Sell
2,121
-273
-11% -$17.2K 0.05% 130
2020
Q1 		$142K Buy
2,394
+25
+1% +$1.67K 0.06% 98
2019
Q4 		$176K Hold
2,369
– – 0.1% 124
2019
Q3 		$149K Hold
2,369
– – 0.09% 127
2019
Q2 		$129K Buy
2,369
+80
+3% +$4.31K 0.08% 131
2019
Q1 		$124K Sell
2,289
-1,110
-33% -$68.5K 0.08% 133
2018
Q4 		$223K Buy
+3,399
New +$254K 0.16% 104

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Prestige Wealth Management Group's CVS Position: Q2 2026 in Review

Prestige Wealth Management Group reduced its CVS Health (CVS) stake by 37% in Q2 2026, selling an estimated $175K and leaving 3,341 shares worth $346K. The position accounts for 0.06% of the portfolio, ranked #130.

Prestige Wealth Management Group first reported a position in CVS in Q4 2018 and has held it in 31 quarters since. The position peaked at $631K in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Prestige Wealth Management Group held 3,341 shares of CVS Health worth $346K as of Q2 2026.
  • Prestige Wealth Management Group sold 1,965 CVS Health shares in Q2 2026, an estimated $175K.
  • CVS Health made up 0.06% of Prestige Wealth Management Group's portfolio in Q2 2026, its #130 holding.
  • Prestige Wealth Management Group first reported a position in CVS Health in Q4 2018 and has held it in 31 quarters since.
  • Prestige Wealth Management Group's CVS Health position peaked at $631K in Q3 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.